Advance Search
ZOU Xianshun, LIU Lisheng, TANG Jinmei, YANG Hui. Effect observation of recombinant human erythropoietin combined with iron sucrose in treatment of anemia patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 77-80. DOI: 10.7619/jcmp.202018022
Citation: ZOU Xianshun, LIU Lisheng, TANG Jinmei, YANG Hui. Effect observation of recombinant human erythropoietin combined with iron sucrose in treatment of anemia patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 77-80. DOI: 10.7619/jcmp.202018022
shu

Effect observation of recombinant human erythropoietin combined with iron sucrose in treatment of anemia patients with maintenance hemodialysis

  • Department of Nephrology, The Fourth People's Hospital of Lianyungang City in Jiangsu Province, Lianyungang, Jiangsu, 222023

More Information
  • Received Date: July 10, 2020
    Graphical Abstract
    • Abstract
  • Objective To investigate the clinical effect of recombinant human erythropoietin combined with iron sucrose in treatment of anemia patients with maintenance hemodialysis. Methods Totally 64 anemia patients with maintenance hemodialysis were selected and randomly divided into control group and observation group, with 32 cases in each group. The control group was treated with iron sucrose, while the observation group was treated with recombinant human erythropoietin on the basis of the control group. Both groups were treated for 8 weeks. The clinical effect, the red blood cell parameters, iron metabolism indexes and inflammation indexes before and after treatment as well as adverse reactions were compared between the two groups. Results The total effective rate of the observation group was 84.38%, which was significantly higher than 65.63% of the control group(P<0.05). After treatment, levels of hematocrit(Hct), hemoglobin(Hb), transferrin saturation(TSAT)and ferritin(SF)in both groups were significantly higher than those before treatment, and the indexes mentioned above in the observation group were significantly higher than those in the control group(P<0.05). After treatment, the levels of tumor necrosis factor-α(TNF-α), interleukin-6(IL-6)and high sensitivity C-reactive protein(hs-CRP)in the observation group were significantly lower than those in the control group(P<0.05). No obvious adverse reactions were found in both groups during the treatment. Conclusion Recombinant human erythropoietin combined with iron sucrose is effective in treatment of anemia patients with maintenance hemodialysis, which can improve the iron metabolism of patients, promote the metabolism of red blood cells, and reduce the levels of - inflammatory factors.
    • FullText(HTML)
    • References (20)
  • 李垚瑶, 李梦思, 郑艳丹, 等. 维持性血液透析患者铁代谢水平对心脏结构及功能的影响[J]. 临床肾脏病杂志, 2018, 18(1): 12-16.
    DEIRA J, GONZÁLEZ-SANCHIDRIÁN S, POLANCO S, et al. Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients[J]. Ren Fail, 2016, 38(7): 1076-1081.
    江强. 生血宁与蔗糖铁联合左卡尼汀对MHD贫血患者氧化应激及红细胞参数的影响[J]. 医学临床研究, 2017, 34(9): 1776-1778.
    PETRULIENÉK, ŽIGINSKIENÉE, KUZMINSKIS V, et al. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients[J]. Medicina, 2017, 53(2): 90-100.
    孙培荣, 马列清, 刘凯燕, 等. 重组人促红细胞生成素治疗维持性血液透析肝病患者肾性贫血的疗效观察[J]. 临床药物治疗杂志, 2015, 13(3): 80-82.
    李才洪, 冯向峰, 薛松. 重组人红细胞生成素联合铁制剂治疗维持性血液透析患者疗效观察[J]. 疑难病杂志, 2014, 13(8): 810-813.
    中国医师协会肾内科医师分会肾性贫血诊断和治疗共识专. 肾性贫血诊断与治疗中国专家共识(2014修订版)[J]. 中华肾脏病杂志, 2014, 30(9): 712-716.
    王亚平. 肾性贫血规范化治疗的新策略[J]. 中国血液净化, 2012, 11(9): 472-475.
    王文素, 周建伟, 张倩, 等. 血液灌流对维持性血液透析患者肾性贫血和微炎症状态的影响[J]. 河北医科大学学报, 2016, 37(5): 585-588.
    FUKAO W, HASUIKE Y, YAMAKAWA T, et al. Oral Versus Intravenous Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients on Maintenance Hemodialysis-Effect on Fibroblast Growth Factor-23 Metabolism[J]. J Ren Nutr, 2018, 28(4): 270-277.
    吴艳萍, 王小琴. 血液透析患者肾性贫血的维持性补铁方式研究[J]. 临床肾脏病杂志, 2017, 17(8): 482-485.
    张蕖, 生血宁联合促红细胞生成素治疗血液透析患者肾性贫血的疗效[J]. 安徽医学, 2017, 38(4): 453-455.
    MARUYAMA T, HIGUCHI T, YAMAZAKI T, et al. Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia[J]. Cardiorenal Medicine, 2017, 7(3): 188-197.
    刘宏敏, 王湘川, 邹立华. 两种透析方式联合蔗糖铁改善肾性贫血临床研究[J]. 临床军医杂志, 2016, 44(12): 1215-1218.
    WAN L, ZHANG D. Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients[J]. Int Urol Nephrol, 2018, 50(8): 1511-1518.
    CHENG X, YU G J, HU J P, et al. Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients[J]. Exp Ther Med, 2016, 12(1): 157-160.
    胡军建. 肾康注射液联合重组人促红细胞生成素治疗慢性肾功能衰竭合并肾性贫血的疗效观察[J]. 现代药物与临床, 2017, 32(2): 314-318.
    管媛媛. EPO生成素联合蔗糖铁治疗对血液透析肾性贫血患者血清学指标及微炎症状态的影响[J]. 海南医学院学报, 2015, 21(8): 1091-1093.
    易晔, 卢远航, 冀倩倩. 生血宁和蔗糖铁对血液透析患者贫血、氧化应激及微炎症影响的比较[J]. 中国药房, 2016, 27(5): 660-662.
    吴韵华, 陆焕俊, 王健生. 蔗糖铁联合重组人促红素注射液治疗血液透析患者肾性贫血的疗效观察[J]. 贵州医药, 2018, 42(10): 1188-1189.
    • Related Articles

  • Related Articles

    [1]HAN Zhongkui, SUO Liujun, WANG Yonghui, XIA Yuanliang. The impact of digital subtraction angiography guided neurointerventional thrombectomy combined with intravenous thrombolysis by tirofiban in acute cerebral infarction patients[J]. Journal of Clinical Medicine in Practice, 2024, 28(2): 8-12. DOI: 10.7619/jcmp.20233234
    [2]LI Jianyi, XU Yan, WANG Junpeng, LIU Zhenguo. Value of coronary CT angiography in quantitative assessment and prognostic assessment of plaque in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 30-32. DOI: 10.7619/jcmp.201919008
    [3]WANG Junwen. Analysis in the risk factors of digital subtraction angiography-induced cerebral embolism of patients with cerebral infarction in subacute stage[J]. Journal of Clinical Medicine in Practice, 2016, (23): 16-19. DOI: 10.7619/jcmp.201623005
    [4]FANG Yin, XIE Wei, SHA Zhenghong, XU Tao, KOU Keren. Significance of CT angiography and digital subtraction angiography in preoperative evaluation of patients with non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2016, (13): 22-24,28. DOI: 10.7619/jcmp.201613007
    [5]WANG Chun, CHEN Jian, WANG Xiu, JIN Gang, ZHANG Beiguang, SUN Zhiqiang, YU Shilong. Application of 3D-CT in treatment of vertebral metastases by percutaneous vertebroplasty[J]. Journal of Clinical Medicine in Practice, 2014, (21): 49-51. DOI: 10.7619/jcmp.201421014
    [6]CHEN Jinan, CHEN Laiming, SHEN Xin, LI Shenghua, LI Junrong. A comparative study in diagnosis of cerebral infarction after transient ischemic attack in the near future between ABCD2 combined with digital subtract angiography or transcranial Doppler[J]. Journal of Clinical Medicine in Practice, 2013, (24): 20-23. DOI: 10.7619/jcmp.201324006
    [7]ZHU Li, XU Yu. Comparison on the application value of 64-slice spiral computed tomography angiography with digital subtraction angiography in the diagnosis of lower extremity arterial disease[J]. Journal of Clinical Medicine in Practice, 2013, (5): 72-74. DOI: 10.7619/jcmp.201305022
    [8]HUANG Wenhua, WANG Yibo. Application of flat digital subtraction angiography in lower limb vein angiography[J]. Journal of Clinical Medicine in Practice, 2012, (24): 84-85.
    [9]TANG Chuan, WANG Yong, LI Zhiwei. Study of digital subtraction angiography in patients with vertebrobasilar insufficiency[J]. Journal of Clinical Medicine in Practice, 2012, (19): 35-37.
    [10]GAO Xia, WANG Min. Nursing of 6 patients with moyamoya disease after digital subtraction angiography[J]. Journal of Clinical Medicine in Practice, 2012, (6): 29-31. DOI: 10.3969/j.issn.1672-2353.2012.06.012

  • Cited by

    Periodical cited type(8)

    1. 黄兴伟，叶开颂，杨瑞党. 无创正压通气联合纳洛酮治疗AECOPD并发呼吸衰竭患者的临床疗效. 临床合理用药. 2023(03): 1-4 .
    2. 姚观金. 纳洛酮联合无创正压通气在慢性阻塞性肺疾病急性加重期并发呼吸衰竭患者中的应用效果. 现代医学与健康研究电子杂志. 2022(07): 86-89 .
    3. 岳莉莉. BiPAP联合纳洛酮治疗慢性阻塞性肺疾病急性加重期伴呼吸衰竭的效果. 中国实用医刊. 2021(08): 68-71 .
    4. 吕美珍，谢靖红，张崇荣. 纳洛酮联合无创呼吸机对慢性阻塞性肺疾病合并慢性呼吸衰竭的影响. 实用医院临床杂志. 2021(06): 142-145 .
    5. 贾素花，王国丽. 老年慢性阻塞性肺疾病合并呼吸衰竭危险因素分析. 社区医学杂志. 2020(04): 260-263 .
    6. 朱霞. 肺间质纤维化并发呼吸衰竭的护理. 实用临床医药杂志. 2018(10): 108-110 . 本站查看
    7. 程茹，张明华，俞万钧. 通腑平喘汤对老年慢性阻塞性肺疾病合并呼吸衰竭的疗效及FVC、FEV1/FVC水平的影响. 中华中医药学刊. 2018(07): 1653-1656 .
    8. 杨帮坤，吴庆龙，吴永仔. 纳洛酮治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者的疗效及安全性. 中国药物经济学. 2018(08): 86-88 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(8)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return